- World rank, all time
- #31,339 of 42,892
- Rank in Italy
- #837 of 969
- Research works
- 274 ▲ 60% vs 2013–17
- Citations
- 4.1k 15.1 per fractional work
- Top-10% rate
- 11.2% record average 16.5%
- Open access
- 35% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 11.2×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 11.2×
- Neuroscience 6.0×
- Nursing 2.9×
- Medicine 2.5×
- Psychology 2.3×
- Dentistry 2.1×
- Immunology and Microbiology 1.9×
- Chemistry 1.8×
- Biochemistry, Genetics and Molecular Biology 1.7×
- Veterinary 1.6×
- Economics, Econometrics and Finance 1.0×
- Agricultural and Biological Sciences 0.4×
- Mathematics 0.4×
- Health Professions 0.4×
- Arts and Humanities 0.3×
- Business, Management and Accounting 0.3×
- Social Sciences 0.3×
- Environmental Science 0.2×
- Engineering 0.1×
- Earth and Planetary Sciences 0.1×
- Computer Science 0.0×
Who are the top researchers at Angelini Pharma (Italy)?
Ranked on the composite score, B Catanese lead among researchers whose main affiliation is Angelini Pharma (Italy).
- 1 B Catanese Italy · #1,101,047 worldwide 15 citations · 15 works
Which keywords describe research at Angelini Pharma (Italy)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Depression, Synaptic Plasticity, Inflammation, Neurobiology, Clinical Guidelines, Genetics, Cognitive Impairment and Treatment-Resistant Depression.
- Quality of Life
- Dendritic Spines
- Microglia
- Cytokines
- Prevalence
- Neurocognitive Deficits
- Neuroinflammation
- Metabolic Syndrome
- Antidepressant
- Genetics
- Clinical Guidelines
- Synaptic Plasticity
- Inflammation
- Depression
- Epidemiology
- Neurobiology
- Cognitive Impairment
- Treatment-Resistant Depression
- Ketamine
- Oxidative Stress
- Antipsychotic Drugs
- Meta-Analysis
- Antiepileptic Drugs
- Epilepsy
- Cognitive Function
- Neurological Disorders
- Anxiety
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 27 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 27 words, with their numbers
- Depression5▲ 14×10 topics
- Inflammation4▲ 4.5×14 topics
- Epidemiology3▲ 2.3×18 topics
- Synaptic Plasticity3▲ 38×2 topics
- Neurobiology3▲ 28×6 topics
- Clinical Guidelines2▲ 22×2 topics
- Cognitive Impairment2▲ 24×2 topics
- Genetics2▲ 9.0×4 topics
- Treatment-Resistant Depression2▲ 96×2 topics
- Antidepressant2▲ 248×1 topic
- Ketamine2▲ 248×1 topic
- Metabolic Syndrome2▲ 7.0×3 topics
- Oxidative Stress2▲ 3.4×10 topics
- Neuroinflammation2▲ 19×4 topics
- Antipsychotic Drugs2▲ 128×1 topic
- Neurocognitive Deficits2▲ 128×1 topic
- Meta-Analysis2▲ 7.5×3 topics
- Prevalence2▲ 9.7×3 topics
- Antiepileptic Drugs1▲ 47×2 topics
- Cytokines1▲ 11×2 topics
- Epilepsy1▲ 29×3 topics
- Microglia1▲ 28×2 topics
- Cognitive Function1▲ 16×2 topics
- Dendritic Spines1▲ 38×2 topics
- Neurological Disorders1▲ 5.2×3 topics
- Quality of Life1▲ 2.1×7 topics
- Anxiety1▲ 5.7×6 topics
Which research topics does Angelini Pharma (Italy) publish most on?
By volume in 2022–2025: Treatment of Major Depression, Schizophrenia research and treatment, Epilepsy research and treatment and Neuroscience and Neuropharmacology Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Treatment of Major Depression Pharmacology 2 works
- 2 Schizophrenia research and treatment Psychiatry and Mental health 2 works
- 3 Epilepsy research and treatment Psychiatry and Mental health 1 works
- 4 Neuroscience and Neuropharmacology Research Cellular and Molecular Neuroscience 1 works
- 5 Tryptophan and brain disorders Biological Psychiatry 1 works
- 6 Pain Mechanisms and Treatments Physiology 1 works
- 7 Bipolar Disorder and Treatment Psychiatry and Mental health 1 works
- 8 Attention Deficit Hyperactivity Disorder Psychiatry and Mental health 1 works
- 9 Sleep and related disorders Experimental and Cognitive Psychology 1 works
- 10 Child and Adolescent Psychosocial and Emotional Development Clinical Psychology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Angelini Pharma (Italy)'s research output changed?
Output in 2018–2022 was 60% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Rome
- Sapienza University of Rome
- University of Rome Tor Vergata
- Istituti di Ricovero e Cura a Carattere Scientifico
- National Research Council
- Roma Tre University
- Istituto Superiore di Sanità
- National Agency for New Technologies, Energy and Sustainable Economic Development
- Agostino Gemelli University Polyclinic
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.